NYSE:PRGOPharmaceuticals
Perrigo (PRGO) Q4 Earnings Collapse With US$10.15 EPS Loss Tests Turnaround Narrative
Perrigo FY 2025 headline results
Perrigo (PRGO) has wrapped up FY 2025 with fourth quarter revenue of US$1,109.6 million, a basic EPS loss of US$10.15 and trailing twelve month revenue of US$4.3 billion alongside a basic EPS loss of US$10.12. Over the past six reported quarters, revenue has moved in a tight band between US$1,043.3 million and US$1,138.3 million, while EPS has swung from a small profit of US$0.09 in Q3 2025 to quarterly losses such as US$0.30 in Q4 2024 and US$10.15 in Q4...